Company / Cash & Equivalents
Select Medical Holdings, Corp. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$26.5M
FY2025
5-year range
$26.5M / $97.9M
FY2021-FY2025
Trend
-55.6%
vs FY2024
Sector context
#144 of 148
Health Care
What the data says
Among 148 Health Care companies, Select Medical Holdings, Corp. is in the bottom 3% for cash & equivalents. Cash & Equivalents has declined for 3 consecutive years, from $98M in FY2022 to $27M in FY2025.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of -46.0%.
Declined from $84M to $27M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -35.3%
- 5-Year CAGR
- -46.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 148This company $26.5M Sector average $1.2B
▼
-97.7% below sector average
Key checks
Key Insights
- Select Medical Holdings, Corp.'s cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of -46.0%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 55.6% year-over-year.
- Ranks #144 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.5M | -55.6% |
| FY2024 | $59.7M | -28.9% |
| FY2023 | $84.0M | -14.2% |
| FY2022 | $97.9M | +31.8% |
| FY2021 | $74.3M | -87.1% |
| FY2020 | $577.1M | +71.8% |
| FY2019 | $335.9M | +174.1% |
| FY2018 | $122.5M | +749.0% |
| FY2017 | $14.4M | -85.4% |
| FY2016 | $99.0M | +2192.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026